(Q45259850)
Statements
Atomoxetine safety and efficacy in children with attention deficit/hyperactivity disorder (ADHD): initial phase of 10-week treatment in a relapse prevention study with a Spanish sample (English)
Escobar R
San Sebastián J
Fernández E